57 related articles for article (PubMed ID: 20812225)
1. Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes.
Brusa D; Carletto S; Cucchiarale G; Gontero P; Greco A; Simone M; Ferrando U; Tizzani A; Matera L
Prostate; 2011 Mar; 71(4):344-52. PubMed ID: 20812225
[TBL] [Abstract][Full Text] [Related]
2. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.
van der Molen RG; Sprengers D; Binda RS; de Jong EC; Niesters HG; Kusters JG; Kwekkeboom J; Janssen HL
Hepatology; 2004 Sep; 40(3):738-46. PubMed ID: 15349914
[TBL] [Abstract][Full Text] [Related]
3. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
[TBL] [Abstract][Full Text] [Related]
4. Ebola and Marburg virus-like particles activate human myeloid dendritic cells.
Bosio CM; Moore BD; Warfield KL; Ruthel G; Mohamadzadeh M; Aman MJ; Bavari S
Virology; 2004 Sep; 326(2):280-7. PubMed ID: 15302213
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
[TBL] [Abstract][Full Text] [Related]
6. Human monocyte-derived dendritic cells pulsed with wild-type p53 protein efficiently induce CTLs against p53 overexpressing human cancer cells.
Tokunaga N; Murakami T; Endo Y; Nishizaki M; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2005 Feb; 11(3):1312-8. PubMed ID: 15709203
[TBL] [Abstract][Full Text] [Related]
7. T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties.
Ferlazzo G; Semino C; Meta M; Procopio F; Morandi B; Melioli G
Eur J Immunol; 2002 Nov; 32(11):3092-101. PubMed ID: 12385029
[TBL] [Abstract][Full Text] [Related]
8. Generation of immune inhibitory dendritic cells and CD4+T regulatory cells inducing by TGF-beta.
Abediankenari S; Ghasemi M
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):25-30. PubMed ID: 19279356
[TBL] [Abstract][Full Text] [Related]
9. Both a precursor and a mature population of dendritic cells can bind HIV. However, only the mature population that expresses CD80 can pass infection to unstimulated CD4+ T cells.
Weissman D; Li Y; Orenstein JM; Fauci AS
J Immunol; 1995 Oct; 155(8):4111-7. PubMed ID: 7561124
[TBL] [Abstract][Full Text] [Related]
10. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
[TBL] [Abstract][Full Text] [Related]
11. Migration and maturation of human dendritic cells infected with Toxoplasma gondii depend on parasite strain type.
Diana J; Persat F; Staquet MJ; Assossou O; Ferrandiz J; Gariazzo MJ; Peyron F; Picot S; Schmitt D; Vincent C
FEMS Immunol Med Microbiol; 2004 Nov; 42(3):321-31. PubMed ID: 15477046
[TBL] [Abstract][Full Text] [Related]
12. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
Canque B; Camus S; Yagello M; Gluckman JC
Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts.
Li L; Giannopoulos K; Reinhardt P; Tabarkiewicz J; Schmitt A; Greiner J; Rolinski J; Hus I; Dmoszynska A; Wiesneth M; Schmitt M
Int J Oncol; 2006 Apr; 28(4):855-61. PubMed ID: 16525634
[TBL] [Abstract][Full Text] [Related]
14. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA
Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543
[TBL] [Abstract][Full Text] [Related]
15. CD83+ human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: A potential tool for gene immunotherapy.
Lohmann S; Galle K; Knop J; Enk AH
Cancer Gene Ther; 2000 Apr; 7(4):605-14. PubMed ID: 10811479
[TBL] [Abstract][Full Text] [Related]
16. Diverse functional activity of CD83+ monocyte-derived dendritic cells and the implications for cancer vaccines.
Czerniecki BJ; Cohen PA; Faries M; Xu S; Roros JG; Bedrosian I
Crit Rev Immunol; 2001; 21(1-3):157-78. PubMed ID: 11642602
[TBL] [Abstract][Full Text] [Related]
17. Adhesion receptors involved in clustering of blood dendritic cells and T lymphocytes.
Scheeren RA; Koopman G; Van der Baan S; Meijer CJ; Pals ST
Eur J Immunol; 1991 May; 21(5):1101-5. PubMed ID: 1709862
[TBL] [Abstract][Full Text] [Related]
18. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.
Lu L; Qian S; Hershberger PA; Rudert WA; Lynch DH; Thomson AW
J Immunol; 1997 Jun; 158(12):5676-84. PubMed ID: 9190916
[TBL] [Abstract][Full Text] [Related]
19. Numerical and functional assessment of blood dendritic cells in prostate cancer patients.
Wilkinson R; Kassianos AJ; Swindle P; Hart DN; Radford KJ
Prostate; 2006 Feb; 66(2):180-92. PubMed ID: 16173035
[TBL] [Abstract][Full Text] [Related]
20. Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
Degl'Innocenti E; Grioni M; Capuano G; Jachetti E; Freschi M; Bertilaccio MT; Hess-Michelini R; Doglioni C; Bellone M
Cancer Res; 2008 Jan; 68(1):292-300. PubMed ID: 18172322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
